ATARA BIOTHERAPEUTICS, INC. Investment Income, Amortization of Premium
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Investment Income, Amortization of Premium of $358.00 thousand for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-11.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeAmortizationOfPremium · last filed 2015-05-11
- ATARA BIOTHERAPEUTICS, INC. investment income, amortization of premium for the quarter ending 2015-03-31 was $358.00K, a 2137.50% increase year-over-year.
- ATARA BIOTHERAPEUTICS, INC. investment income, amortization of premium for the quarter ending 2014-12-31 was $277.00K.
- ATARA BIOTHERAPEUTICS, INC. investment income, amortization of premium for the quarter ending 2014-03-31 was $16.00K.
- ATARA BIOTHERAPEUTICS, INC. investment income, amortization of premium for fiscal 2014 was $526.00K.
| Period end | Investment Income, Amortization of Premium 3 month | Investment Income, Amortization of Premium 6 month | Investment Income, Amortization of Premium 9 month | Investment Income, Amortization of Premium 12 month |
|---|---|---|---|---|
| 2015-03-31 | $358.00K 10-Q · filed 2015-05-11 | $635.00K derived: sum of 2 quarters · filed 2015-05-11 | ||
| 2014-12-31 | $277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $526.00K 10-K · filed 2015-02-26 | ||
| 2014-09-30 | $249.00K 10-Q · filed 2014-11-12 | |||
| 2014-03-31 | $16.00K 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |